Profitelligence Profitelligence · Filing Ledger Sign up free →

31 filings · most recent first

DXCM 8-K Filings

Dexcom Reports Strong Q2 2026 Financial Results And Raises Guidance Dexcom Inc Announces Results Of 2026 Annual Meeting Of Stockholders Dexcom Announces Investor Day Insights And New Share Repurchase Program Dexcom Reports Strong Q1 2026 Financial Results And Raises Guidance Dexcom Ceo Retires And Transitions To Executive Chairman Role Dexcom Appoints Rick Osterloh To Board Of Directors Dexcom Reports Strong 2025 Financial Results And Strategic Achievements Dexcom Reports Preliminary Q4 And Fy 2025 Results Provides Fy 2026 Outlook Dexcom Appoints New Ceo Jacob S Leach Effective January 1 2026 Dexcom Reports Strong Q3 2025 Financial Results And Updates Guidance Dexcom Appoints Dr Euan Ashley To Board Of Directors Dexcom Ceo Takes Temporary Medical Leave Interim Appointments Made Dexcom Announces Strong Q2 2025 Results And Ceo Succession Plan Dexcom Promotes Jake Leach To President And Coo Dexcom Appoints Rene Gal To Board And Key Committees Dexcom Announces Amendments To Equity Incentive Plan And Election Of Board Dexcom Director Karen Dahut Resigns From Board Dexcom Announces Q1 2025 Financial Results And 750M Share Repurchase Program Dexcom Inc Announces Change In Independent Registered Public Accounting Firm Dexcom Appoints Rene Gal To Board Of Directors Fda Warning Letter Received By Dexcom Inc Dexcom Reports 2024 Financial Results And Strategic Highlights Dexcom Reports Fourth Quarter 2024 And Fiscal Year 2024 Preliminary Results Dexcom And Abbott Settle Patent Litigation With Crosslicensing Agreement Dexcom Reports Q3 2024 Financial Results With Revenue Growth And Strategic Dexcom Reports Q2 2024 Financial Results And Announces Share Repurchase Program Dexcom Inc Announces Voting Results From 2024 Annual Meeting Of Stockholders Dexcom Reports Strong Q1 2024 Financial Results And Strategic Advancements Dexcom Inc Terminates Outstanding Warrants With Bank Of America Dexcom Reports Strong Q4 2023 Financial Results And Strategic Highlights Dexcom Announces Preliminary Fy 2023 Revenue And Fy 2024 Outlook
DXCM full research: price, insiders, financials →